e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

184.25 -1.02 (-0.55%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall ↗

April 25, 2022

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗

April 25, 2022

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Via Benzinga

Axsome Therapeutics' Good Fortune Reverses As Its Migraine Drug Hits A Hurdle ↗

April 25, 2022

Last week, Axsome stock soared on its depression drug. This week is a different story.

Via Investor's Business Daily

Why Axsome Therapeutics Stock Is Falling Today ↗

April 25, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company reported it was informed by the U.S. Food and Drug Administration (FDA) that...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...

Via Benzinga

Dow Up Over 400 Points as Wall Street Pores Over Earnings ↗

April 19, 2022

Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season.

Via Talk Markets

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

Hydrogen Stocks News: Why Are PLUG, FCEL, BE Stocks Up Today? ↗

April 19, 2022

Hydrogen stocks are in the news Tuesday as several companies see their shares head higher today thanks to a massive deal.

Via InvestorPlace

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗

April 19, 2022

Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA.

Via InvestorPlace

Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent ↗

April 19, 2022

The company agreed to the FDA's post-marketing requirements for a depression drug.

Via Investor's Business Daily

Axsome Therapeutics Stock Is Surging: Here's Why ↗

April 19, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed...

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More ↗

April 19, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates ↗

April 01, 2022

Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...

Via Benzinga

Peering Into Axsome Therapeutics Inc's Recent Short Interest ↗

March 30, 2022

Axsome Therapeutics Inc's (NASDAQ:AXSM) short percent of float has risen 15.16% since its last report. The company recently reported that it has 4.42 million shares sold short,...

Via Benzinga

Why Axsome Therapeutics Stock Is Trading Higher ↗

March 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ).

Via Benzinga

Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio ↗

March 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) has

Via Benzinga

Best Biotech Stocks To Buy In 2022 ↗

March 15, 2022

Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...

Via Talk Markets

Axsome Therapeutics: Q4 Earnings Insights ↗

March 01, 2022

Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 07, 2022

Gainers Agile Therapeutics (NASDAQ:AGRX) ...

Via Benzinga

Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics ↗

February 02, 2022

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 07, 2022

Gainers ContraFect (NASDAQ:CFRX) stock mo...

Via Benzinga

2 Top Biotech Stocks Ready for a Bull Run ↗

November 24, 2021

Both of these companies have potential catalysts on the way.

Via The Motley Fool

Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript ↗

November 08, 2021

AXSM earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Axsome Therapeutics Stock Is Rising Today ↗

November 08, 2021

The company provided its third-quarter update.

Via The Motley Fool

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy